Hypertension-Driven Regulatory T-Cell Perturbations Accelerate Myocardial Ischemia-Reperfusion Injury

Area of Science:

• Immunology
• Cardiovascular Medicine
• Pathophysiology

Background:

• Hypertension is linked to increased inflammation and poorer prognosis following acute myocardial infarction (AMI).
• Regulatory T cells (Tregs) may lose function in pathological states, but their role in hypertension-accelerated myocardial ischemia-reperfusion injury is unclear.

Purpose of the Study:

• To investigate whether hypertension induces regulatory T cell (Treg) dysfunction.
• To determine if Treg dysfunction exacerbates myocardial ischemia-reperfusion injury in hypertensive conditions.
• To explore potential therapeutic targets for hypertensive patients with AMI.

Main Methods:

• Studies in hypertensive rats and mice with myocardial ischemia-reperfusion injury.
• Flow cytometry and immunohistochemistry to analyze Treg frequencies and phenotypes.
• Reconstruction Treg experiments to assess Treg effects on injury.
• Clinical evaluation of circulating Tregs, inflammatory cytokines, and cardiac function in AMI patients.

Main Results:

• Hypertension induced proinflammatory T helper 1 (Th1)-like Treg subsets with reduced suppressive capacity.
• Dysfunctional Tregs exacerbated myocardial ischemia-reperfusion injury.
• Histone deacetylase 6 (HDAC6) was identified as a key regulator in perturbed Tregs.
• Reduced circulating Tregs in hypertensive AMI patients correlated with increased microvascular obstruction.

Conclusions:

• Hypertension-induced Treg alterations contribute to the poor prognosis in AMI patients.
• Targeting dysfunctional Tregs presents a novel therapeutic strategy for treating AMI in hypertensive individuals.